November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes data from of peripheral vascular interventions guided by intravascular ultrasound (IVUS) showed a  32% reduction in major adverse limb events, such as amputations, during lower extremity arterial intervention. 

November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage (LAA) transcatheter occluder with the new generation Boston Scientific Watchman FLX transcatheter occluder.

November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated favorable patient outcomes were sustained at six months. Results from the TRISCEND study, treating patients with tricuspid regurgitation, were presented during the late-breaking clinical science session at the 2021 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting of the Cardiovascular Research Foundation.

November 5, 2021 – An FDA-approved device used during cardiac cath lab procedures cut radiation exposure for cardiologists, nurses and other medical staff in half, according to a study conducted by Beaumont Health, the largest health system in Michigan. 

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection. Recent small-sample studies (fewer than 200 patients) have suggested that statins, cholesterol-lowering drugs that lower levels of low-density lipoprotein (LDL), also may reduce the chances of severe disease or death from COVID-19.

Katherine Fornell, age 5, from suburban Chicago, receives her first dose of the COVID-19 vaccine during the first week it became available in the U.S. The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. This was based on a safety review of more than 3,000 patients receiving the vaccine ages 5-11.

November 5, 2021 — The U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine Oct. 29 for the prevention of COVID-19 in children 5 to 11 years of age. 

The emergency use authorization (EUA) was based on the FDA’s evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.
American Society of Nuclear Cardiology (ASNC) President Randy Thompson, M.D., getting his COVID-19 vaccine when the vaccines first became available last December. Nearly a year later, some healthcare workers are still holding out and refuse to get the vaccine, which prompted CMS (Medicare) to now require COVID vaccinations for all healthcare workers at facilities that accept Medicare and Medicaid patients.

November 4, 2021 — The Centers for Medicare and Medicaid Services (CMS) today issued an emergency regulation now requiring COVID-19 vaccinations for all eligible staff at healthcare facilities that participate in the Medicare and Medicaid programs. 

CMS has set a deadline of Dec. 5 for healthcare facilities to create a COVID vaccination requirement policy and  a deadline of Jan. 4, 2022 for all staff at these facilities to be fully vaccinated.

November 2, 2021 — Cardionomic Inc. announce initial U.S. enrollment in its global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study (NCT04814134). The study is evaluating the safety and performance of the CPNS System in patients suffering from acute decompensated heart failure (ADHF), defined as new or worsening symptoms of heart failure. 

 November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) because of reports the battery packs can fail. The U.S. Food and Drug Administration sent out a notice this week that this is a Class I Recall because of the risk of serious injury or death.

November 1, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), radiologists need to be cognizant of the association between coronavirus disease (COVID-19) mRNA vaccination and myocarditis, as well as the role of

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now